TLDR Scalp cooling prevented hair loss in half of the patients, despite significant side effects.
The study investigated the effectiveness of scalp cooling in preventing anthracycline-induced alopecia in 29 early breast cancer patients undergoing chemotherapy. Using the PinguinR scalp cooling system, 51% of patients still developed alopecia, resulting in a 50% success rate for the cooling method. Despite side effects such as pain, headache, dizziness, nausea, and vomiting, 70% of patients favored the treatment. The study concluded that while scalp cooling was effective for half of the patients, the side effects were significant, yet the overall patient appraisal was positive.
17 citations,
June 2020 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” Scalp cooling is an effective way to prevent hair loss from chemotherapy.
1 citations,
January 2018 in “Springer eBooks” The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.
[object Object] 
34 citations,
January 2018 in “International Journal of Dermatology” Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.
37 citations,
October 2017 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” Scalp cooling effectively reduces hair loss from chemotherapy.
62 citations,
February 2011 in “Expert review of dermatology” Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.
